Over the past six years the NAOPH dependent cytochrome P-450 metabolism of arachidonic acid has assumed increasing importance. This Program Project Grant represents a unique collaboration designed to characterize the biochemistry of this pathway and its overall importance to the kidney. Six independent but complimentary projects are proposed: 1) Transport effects of arachidonate P-450 metabolites in defined nephron segments. There is now good reason to believe that P-450 metabolites have important functional effects on sodium transport in proximal tubule, organic ion secretion in proximal tubule, salt transport in the medullary thick ascending limb of Henle, and vasopressin modulated water flow in the cortical collecting tubule. Project 1 will pursue the sites and mechanisms of these direct tubular actions. 2) characterization of renal cytochrome P-450 arachidonate metabolism. This project will characterize the biochemistry of arachidonic acid oxidation in terms of enzymology, metabolite formation, structural characterization, regulation, and localization in the kidney. These studies are critical to the functional studies. 3) Role of cytochrome P-450 arachidonate metabolites in human platelets and their aggregation. Platelet aggregation and release of biologically active products plays an important role in renal disease. Based on the recent demonstration of potent effects of a P-450 metabolite on platelet aggregation, this project will identify P-450 oxygenation products in human platelets, determine their esterification in platelet lipids, examine their effects on agonist induced platelet aggregation, examine their release from activated platelet and determine the mechanism by which they inhibit platelet aggregation. 4) In vivo studies of P-450 metabolites. Studies will test their effects on renal function in vivo utilizing clearance and micropuncture studies in the rat. Preliminary data on profound modulation of P-450 metabolism in experimental models such as unilateral nephrectomy, diabetes, and pregnancy will be pursued. 5) Characterization of a model cell system to study cytochrome P-450 arachidonate metabolites to test their effects on signal transduction pathways, and to determine whether they serve as intracellular second messenger. 6) Characterization and synthesis of renal P-450 eicosnoids, development of strategies to synthesize the metabolites and inhibitors for biological evaluation. We feel that these projects represent an ideal integration of techniques and investigators to address the biological importance of renal cytochrome P-450 arachidonate metabolism.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
2P01DK038226-03
Application #
3095474
Study Section
Diabetes and Digestive and Kidney Diseases Special Grants Review Committee (DDK)
Project Start
1986-05-01
Project End
1993-06-30
Budget Start
1988-08-15
Budget End
1989-06-30
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37203
Elijovich, Fernando; Milne, Ginger L; Brown, Nancy J et al. (2018) Two Pools of Epoxyeicosatrienoic Acids in Humans: Alterations in Salt-Sensitive Normotensive Subjects. Hypertension 71:346-355
Sausville, Lindsay N; Gangadhariah, Mahesha H; Chiusa, Manuel et al. (2018) The Cytochrome P450 Slow Metabolizers CYP2C9*2 and CYP2C9*3 Directly Regulate Tumorigenesis via Reduced Epoxyeicosatrienoic Acid Production. Cancer Res 78:4865-4877
Garcia, Victor; Gilani, Ankit; Shkolnik, Brian et al. (2017) 20-HETE Signals Through G-Protein-Coupled Receptor GPR75 (Gq) to Affect Vascular Function and Trigger Hypertension. Circ Res 120:1776-1788
Guo, Zhijun; Sevrioukova, Irina F; Denisov, Ilia G et al. (2017) Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria. Cell Chem Biol 24:1259-1275.e6
Zhang, Hui; Falck, John R; Roman, Richard J et al. (2017) Upregulation of 20-HETE Synthetic Cytochrome P450 Isoforms by Oxygen-Glucose Deprivation in Cortical Neurons. Cell Mol Neurobiol 37:1279-1286
Gangadhariah, Mahesha H; Dieckmann, Blake W; Lantier, Louise et al. (2017) Cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids contribute to insulin sensitivity in mice and in humans. Diabetologia 60:1066-1075
Shuey, Megan M; Billings 4th, Frederic T; Wei, Shouzou et al. (2017) Association of gain-of-function EPHX2 polymorphism Lys55Arg with acute kidney injury following cardiac surgery. PLoS One 12:e0175292
Fan, Fan; Pabbidi, Mallikarjuna R; Ge, Ying et al. (2017) Knockdown of Add3 impairs the myogenic response of renal afferent arterioles and middle cerebral arteries. Am J Physiol Renal Physiol 312:F971-F981
Imig, J D (2016) Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function. Adv Pharmacol 77:105-41
Savas, Üzen; Wei, Shouzou; Hsu, Mei-Hui et al. (2016) 20-Hydroxyeicosatetraenoic Acid (HETE)-dependent Hypertension in Human Cytochrome P450 (CYP) 4A11 Transgenic Mice: NORMALIZATION OF BLOOD PRESSURE BY SODIUM RESTRICTION, HYDROCHLOROTHIAZIDE, OR BLOCKADE OF THE TYPE 1 ANGIOTENSIN II RECEPTOR. J Biol Chem 291:16904-19

Showing the most recent 10 out of 376 publications